Skip to content
2000
Volume 14, Issue 4
  • ISSN: 1573-4072
  • E-ISSN: 1875-6646

Abstract

Background: Cancer is one of the major health and socio-economic problems of the world even though extensive progress has been made in terms of early diagnosis and cure. The research for new anticancer drug development with more effective treatment is a field of utmost importance in current drug discovery. Method: Molecular Hybridization (MH) strategy has been adapted for the rational design of new ligands, where pharmacophoric sub-unities in the molecular structure of two bioactives will lead to the design of new hybrid architectures. All the synthesized compounds (3a-z) were evaluated in HeLa and MCF-7 cell lines for their anticancer activity and compared against H9C2 normal cells. Results: As expected, among the tested compounds, 3a, 3d, 3g, 3j, 3m and 3s exhibited highest activity with GI50 value of 1.72 μm, 2.10 μm, 4.26 μm, 2.43 μm, 5.11 μm and 4.34μm in HeLa cells and 1.86 μm, 2.50 μm, 5.20 μm, 4.40 μm, 6.14 μm and 5.30 μm in MCF-7 cells respectively. We also found that the compounds were non-toxic to H9C2 cells up to 20 μM. Conclusion: Preliminary structure-activity relationship studies revealed that compounds with para-Cl substituted phenyl and 5-Cl substituted indole on diazepine ring proved to be more potent.

Loading

Article metrics loading...

/content/journals/cbc/10.2174/1573407213666170707150757
2018-12-01
2025-05-23
Loading full text...

Full text loading...

/content/journals/cbc/10.2174/1573407213666170707150757
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test